FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

387047007: Loteprednol etabonate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2003. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1763813019 Loteprednol etabonate (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
1776051014 Loteprednol etabonate en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Loteprednol etabonate Is a Adrenal cortex hormone false Inferred relationship Existential restriction modifier
Loteprednol etabonate Is a Glucocorticoid hormone false Inferred relationship Existential restriction modifier
Loteprednol etabonate Is a Loteprednol false Inferred relationship Existential restriction modifier
Loteprednol etabonate Is modification of Loteprednol true Inferred relationship Existential restriction modifier
Loteprednol etabonate Is a Synthetic glucocorticoid false Inferred relationship Existential restriction modifier
Loteprednol etabonate Has disposition Androgen receptor agonist false Inferred relationship Existential restriction modifier
Loteprednol etabonate Has disposition Gonadal hormone false Inferred relationship Existential restriction modifier
Loteprednol etabonate Is a Androstane true Inferred relationship Existential restriction modifier
Loteprednol etabonate Is a Glucocorticoid true Inferred relationship Existential restriction modifier
Loteprednol etabonate Is a Antilipemic agent true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Loteprednol etabonate ophthalmic preparation Has active ingredient False Loteprednol etabonate Inferred relationship Existential restriction modifier
Product containing precisely loteprednol etabonate 5 milligram/1 milliliter conventional release eye suspension (clinical drug) Has active ingredient False Loteprednol etabonate Inferred relationship Existential restriction modifier
Product containing precisely loteprednol etabonate 2 milligram/1 milliliter conventional release eye suspension (clinical drug) Has active ingredient False Loteprednol etabonate Inferred relationship Existential restriction modifier
Loteprednol etabonate Has active ingredient False Loteprednol etabonate Inferred relationship Existential restriction modifier
Loteprednol etabonate + tobramycin Has active ingredient False Loteprednol etabonate Inferred relationship Existential restriction modifier
Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) Has active ingredient False Loteprednol etabonate Inferred relationship Existential restriction modifier
Product containing precisely loteprednol etabonate 2 milligram/1 milliliter conventional release eye suspension (clinical drug) Has precise active ingredient True Loteprednol etabonate Inferred relationship Existential restriction modifier 1
Product containing precisely loteprednol etabonate 2 milligram/1 milliliter conventional release eye suspension (clinical drug) Has basis of strength substance True Loteprednol etabonate Inferred relationship Existential restriction modifier 1
Product containing precisely loteprednol etabonate 5 milligram/1 milliliter conventional release eye suspension (clinical drug) Has basis of strength substance True Loteprednol etabonate Inferred relationship Existential restriction modifier 1
Product containing precisely loteprednol etabonate 5 milligram/1 milliliter conventional release eye suspension (clinical drug) Has precise active ingredient True Loteprednol etabonate Inferred relationship Existential restriction modifier 1
Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) Has precise active ingredient True Loteprednol etabonate Inferred relationship Existential restriction modifier 2
Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) Has basis of strength substance True Loteprednol etabonate Inferred relationship Existential restriction modifier 2
Loteprednol 0.5% eye drops Has active ingredient False Loteprednol etabonate Inferred relationship Existential restriction modifier
Lotemax 0.5% eye drops (Bausch & Lomb UK Ltd) Has active ingredient False Loteprednol etabonate Inferred relationship Existential restriction modifier
Loteprednol 0.5% eye drops 5 ml Has active ingredient False Loteprednol etabonate Inferred relationship Existential restriction modifier
Lotemax 0.5% eye drops (Bausch & Lomb UK Ltd) 5 ml Has active ingredient False Loteprednol etabonate Inferred relationship Existential restriction modifier
Loteprednol 0.5% eye drops 5 ml Has specific active ingredient True Loteprednol etabonate Inferred relationship Existential restriction modifier
Loteprednol 0.5% eye drops Has specific active ingredient True Loteprednol etabonate Inferred relationship Existential restriction modifier
Lotemax 0.5% eye drops (Bausch & Lomb UK Ltd) Has specific active ingredient True Loteprednol etabonate Inferred relationship Existential restriction modifier
Lotemax 0.5% eye drops (Bausch & Lomb UK Ltd) 5 ml Has specific active ingredient True Loteprednol etabonate Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start